ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization

DOI Web Site 被引用文献2件 参考文献35件 オープンアクセス
  • Sharmila Dorbala
    Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
  • Yukio Ando
    Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan.
  • Sabahat Bokhari
    Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, NY, USA.
  • Angela Dispenzieri
    Division of Hematology, Division of Cardiovascular Diseases, and Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Rodney H. Falk
    Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
  • Victor A. Ferrari
    Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Marianna Fontana
    National Amyloidosis Centre, Division of Medicine, University College London, London, United Kingdom.
  • Olivier Gheysens
    Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
  • Julian D. Gillmore
    National Amyloidosis Centre, Division of Medicine, University College London, London, United Kingdom.
  • Andor W. J. M. Glaudemans
    Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Mazen A. Hanna
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Bouke P. C. Hazenberg
    Department of Rheumatology & Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Arnt V. Kristen
    Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Raymond Y. Kwong
    Cardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
  • Mathew S. Maurer
    Columbia University Medical Center/New York Presbyterian Hospital, Columbia University, NY, USA.
  • Giampaolo Merlini
    Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
  • Edward J. Miller
    Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • James C. Moon
    National Amyloidosis Centre, Division of Medicine, University College London, London, United Kingdom.
  • Venkatesh L. Murthy
    Frankel Cardiovascular Center, Michigan Medicine, Ann Arbor, MI, USA.
  • C. Cristina Quarta
    National Amyloidosis Centre, Division of Medicine, University College London, London, United Kingdom.
  • Claudio Rapezzi
    Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
  • Frederick L. Ruberg
    Amyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
  • Sanjiv J. Shah
    Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Riemer H. J. A. Slart
    Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hein J. Verberne
    Amsterdam UMC, University of Amsterdam, Department of Radiology and Nuclear Medicine, Amsterdam, The Netherlands.
  • Jamieson M. Bourque
    Cardiovascular Imaging Center, Departments of Medicine and Radiology, University of Virginia, Charlottesville, VA, USA.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (35)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ